Literature DB >> 16678595

Comparison of Coapsys annuloplasty and internal reduction mitral annuloplasty in the randomized treatment of functional ischemic mitral regurgitation: impact on the left ventricle.

E A Grossi1, Y J Woo, C F Schwartz, D M Gangahar, V A Subramanian, N Patel, J Wudel, P L DiGiorgi, A Singh, R D Davis.   

Abstract

BACKGROUND: Functional mitral regurgitation is associated with both annular and ventricular distortion. Aggressive reduction annuloplasty for functional mitral regurgitation acts primarily at the annulus, with variable impact on the left ventricle. The Coapsys device externally reshapes the left ventricle to correct functional mitral regurgitation. Left ventricular reshaping was analyzed in a randomized study.
METHODS: The RESTOR-MV study randomizes patients with coronary artery disease and functional mitral regurgitation to either reduction annuloplasty and coronary artery bypass grafting (the RA group) or Coapsys annuloplasty and bypass grafting (the CO group). The Coapsys device consists of epicardial pads connected by a cord. It was placed without cardiopulmonary bypass under echocardiographic guidance and sized to reduce annular dimension and improve leaflet coaptation. Internal reduction annuloplasty was performed by device placement. Intraoperative transesophageal echocardiograms were analyzed in 7 patients having reduction annuloplasty and 7 having Coapsys annuloplasty.
RESULTS: Baseline mitral regurgitation (0-4 scale) was similar for the RA (3.0 +/- 0.6) and the CO groups (3.0 +/- 0.6). Intraoperative mitral regurgitation was reduced from 2.86 +/- 0.7 to 0.5 +/- 0.7 (P < .01 pre vs post) for the RA group and from 2.64 +/- 0.9 to 05 +/- 0.7 (P < .01 pre vs post) for the CO group. Annular anteroposterior diameter was reduced with both techniques: RA, 3.45 +/- 0.39 to 2.34 +/- 0.37 cm (P < .01 pre vs post); CO, 3.40 +/- 0.27 to 2.85 +/- 0.34 cm (P < .05 pre vs post). Long-axis dimensions were unchanged with both techniques. Short-axis dimensions measured at three levels were significantly reduced only in the CO patients: basal diameter 4.77 +/- 0.58 to 3.58 +/- 0.38 cm (P < .01 pre vs post); mid diameter 4.88 +/- 0.55 to 3.57 +/- 0.43 cm (P < .01 pre vs post); and apical diameter 4.39 +/- 0.46 to 3.38 +/- 0.34 cm (P < .01 pre vs post).
CONCLUSIONS: Coapsys and reduction annuloplasty techniques both acutely reduce functional mitral regurgitation and annular dimension. The Coapsys device provided significantly greater left ventricular reshaping than did reduction annuloplasty. Further evaluation will assess the long-term valvular function and ventricular geometric stability associated with both techniques.

Entities:  

Mesh:

Year:  2006        PMID: 16678595     DOI: 10.1016/j.jtcvs.2005.11.046

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  17 in total

1.  Distinct but parallel evolutionary patterns between alcohol and aldehyde dehydrogenases: addition of fish/human betaine aldehyde dehydrogenase divergence.

Authors:  L Hjelmqvist; A Norin; M El-Ahmad; W Griffiths; H Jörnvall
Journal:  Cell Mol Life Sci       Date:  2003-09       Impact factor: 9.261

Review 2.  Therapeutic decision-making for patients with fluctuating mitral regurgitation.

Authors:  Patrizio Lancellotti; Khalil Fattouch; Giovanni La Canna
Journal:  Nat Rev Cardiol       Date:  2015-02-10       Impact factor: 32.419

Review 3.  Current and novel cardiac support therapies.

Authors:  Bodh I Jugdutt
Journal:  Curr Heart Fail Rep       Date:  2009-03

Review 4.  Percutaneous mitral valve repair.

Authors:  Amelia Young; Ted Feldman
Journal:  Curr Cardiol Rep       Date:  2014-01       Impact factor: 2.931

5.  Mitral Loop Cerclage Annuloplasty for Secondary Mitral Regurgitation: First Human Results.

Authors:  Yong-Hyun Park; Min-Ku Chon; Robert J Lederman; Si-Chan Sung; Hyung-Gon Je; Ki-Seok Choo; Sang-Hyun Lee; Eun-Seok Shin; Jeong-Su Kim; Ki-Won Hwang; Soo-Yong Lee; Kook-Jin Chun; Cheol-Min Kim; June-Hong Kim
Journal:  JACC Cardiovasc Interv       Date:  2017-03-27       Impact factor: 11.195

6.  Posterior papillary muscle anchoring affects remote myofiber stress and pump function: finite element analysis.

Authors:  Joe Luis Pantoja; Liang Ge; Zhihong Zhang; William G Morrel; Julius M Guccione; Eugene A Grossi; Mark B Ratcliffe
Journal:  Ann Thorac Surg       Date:  2014-08-15       Impact factor: 4.330

Review 7.  Functional mitral regurgitation: a 30-year unresolved surgical journey from valve replacement to complex valve repairs.

Authors:  Francesco Onorati; Francesco Santini; Rajesh Dandale; Andrea Rossi; Esther Campopiano; Konstantinos Pechlivanidis; Daniele Calzaferri; Aldo Milano; Alessandro Mazzucco; Giuseppe Faggian
Journal:  Heart Fail Rev       Date:  2014-05       Impact factor: 4.214

Review 8.  [Percutaneous mitral annuloplasty with the VIACOR coronary sinus system for the treatment of functional mitral regurgitation in heart failure patients. Development and results].

Authors:  Stefan Sack
Journal:  Herz       Date:  2009-09       Impact factor: 1.443

Review 9.  Percutaneous and off-pump treatments for functional mitral regurgitation.

Authors:  Kiyotaka Fukamachi
Journal:  J Artif Organs       Date:  2008-04-15       Impact factor: 1.731

Review 10.  Finite Element Modeling of Mitral Valve Repair.

Authors:  Ashley E Morgan; Joe Luis Pantoja; Jonathan Weinsaft; Eugene Grossi; Julius M Guccione; Liang Ge; Mark Ratcliffe
Journal:  J Biomech Eng       Date:  2016-02       Impact factor: 2.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.